Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial

BACKGROUND: Interleukin‐6 (IL‐6) is an inflammatory cytokine implicated in plaque instability in acute coronary syndrome (ACS). We aimed to evaluate the prognostic implications of IL‐6 post‐ACS. METHODS AND RESULTS: IL‐6 concentration was assessed at baseline in 4939 subjects in SOLID‐TIMI 52 (Stabi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Fanola, Christina L., Morrow, David A., Cannon, Christopher P., Jarolim, Petr, Lukas, Mary Ann, Bode, Christoph, Hochman, Judith S., Goodrich, Erica L., Braunwald, Eugene, O'Donoghue, Michelle L.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721825/
https://ncbi.nlm.nih.gov/pubmed/29066436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.005637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados